{"transactions":[{"id":4640932,"issuer":{"id":6906,"kind":"organization","name":"iBio, Inc.","symbol":"IBIO"},"owners":[{"id":35282,"kind":"person","name":"Kropotova Alexandra","position":1,"cik":"0001825323","reported_name":"Kropotova Alexandra","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2026-10-15T22:33:12.000Z","date":"2026-10-14","kind":"grant","planned":false,"acquired":true,"shares":38000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The options vest pro rata in monthly installments over twelve months, with the first installment vesting one month after the grant date, subject to the Reporting Person's continued service through each applicable vesting date."},{"field":"shares","element":"transactionShares","label":"F1","text":"The options vest pro rata in monthly installments over twelve months, with the first installment vesting one month after the grant date, subject to the Reporting Person's continued service through each applicable vesting date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options vest pro rata in monthly installments over twelve months, with the first installment vesting one month after the grant date, subject to the Reporting Person's continued service through each applicable vesting date."}],"balance_after":38000,"derivative":{"exercise_price":0.78,"expiration_date":"2036-10-13","underlying":"Common Stock","underlying_shares":38000},"source":{"system":"sec-edgar","filing":"0001104659-26-116321","document":"tm2627695-5_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1825323/000110465926116321/tm2627695-5_4seq1.xml","form_type":"4"}},{"id":4622872,"issuer":{"id":5816,"kind":"organization","name":"SAB Biotherapeutics, Inc.","symbol":"SABS"},"owners":[{"id":35282,"kind":"person","name":"Kropotova Alexandra","position":1,"cik":"0001825323","reported_name":"Kropotova Alexandra","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF MEDICAL OFFICER"}}],"security":"Common Stock","published_at":"2026-09-18T20:15:03.000Z","date":"2026-09-17","kind":"tax_withholding","planned":false,"acquired":false,"shares":473,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares of the Issuer's common stock (\"Common Stock\") withheld to statisfy tax withholding requirements on the vesting of the Issuer's restricked stock units (\"RSUs\")."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Represents shares of the Issuer's common stock (\"Common Stock\") withheld to statisfy tax withholding requirements on the vesting of the Issuer's restricked stock units (\"RSUs\")."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 38,402 shares of Common Stock and 3,433 shares of Common Stock which remain subject to vesting of RSUs granted under the Issuer's 2021 Equity Incentive Plan, as amended."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Each RSU represents a contingent right to receive one share of Common Stock."}],"balance_after":41853,"source":{"system":"sec-edgar","filing":"0001193125-26-395552","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1833214/000119312526395552/ownership.xml","form_type":"4"}},{"id":725967,"issuer":{"id":5816,"kind":"organization","name":"SAB Biotherapeutics, Inc.","symbol":"SABS"},"owners":[{"id":35282,"kind":"person","name":"Kropotova Alexandra","position":1,"cik":"0001825323","reported_name":"Kropotova Alexandra","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF MEDICAL OFFICER"}}],"security":"Common Stock","published_at":"2026-06-26T21:20:02.000Z","date":"2026-06-25","kind":"tax_withholding","planned":false,"acquired":false,"shares":988,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares of the Issuer's common stock (\"Common Stock\") withheld to statisfy tax withholding requirements on the vesting of the Issuer's restricked stock units (\"RSUs\")."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Represents shares of the Issuer's common stock (\"Common Stock\") withheld to statisfy tax withholding requirements on the vesting of the Issuer's restricked stock units (\"RSUs\")."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 37,158 shares of Common Stock and 5,150 shares of Common Stock which remain subject to vesting of RSUs granted under the Issuer's 2021 Equity Incentive Plan, as amended."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Each RSU represents a contingent right to receive one share of Common Stock."}],"balance_after":42308,"source":{"system":"sec-edgar","filing":"0001193125-26-285722","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1833214/000119312526285722/ownership.xml","form_type":"4"}},{"id":828705,"issuer":{"id":5816,"kind":"organization","name":"SAB Biotherapeutics, Inc.","symbol":"SABS"},"owners":[{"id":35282,"kind":"person","name":"Kropotova Alexandra","position":1,"cik":"0001825323","reported_name":"Kropotova Alexandra","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF MEDICAL OFFICER"}}],"security":"Common Stock","published_at":"2026-03-25T20:35:02.000Z","date":"2026-03-24","kind":"tax_withholding","planned":false,"acquired":false,"shares":988,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares of the Issuer's common stock (\"Common Stock\") withheld to statisfy tax withholding requirements on the vesting of the Issuer's restricked stock units (\"RSUs\")."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Represents shares of the Issuer's common stock (\"Common Stock\") withheld to statisfy tax withholding requirements on the vesting of the Issuer's restricked stock units (\"RSUs\")."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 34,553 shares of Common Stock and 8,743 shares of Common Stock which remain subject to vesting of RSUs granted under the Issuer's 2021 Equity Incentive Plan, as amended."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Each RSU represents a contingent right to receive one share of Common Stock."}],"balance_after":43296,"source":{"system":"sec-edgar","filing":"0001193125-26-124231","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1833214/000119312526124231/ownership.xml","form_type":"4"}},{"id":918395,"issuer":{"id":5816,"kind":"organization","name":"SAB Biotherapeutics, Inc.","symbol":"SABS"},"owners":[{"id":35282,"kind":"person","name":"Kropotova Alexandra","position":1,"cik":"0001825323","reported_name":"Kropotova Alexandra","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF MEDICAL OFFICER"}}],"security":"Stock option (right to buy)","published_at":"2026-02-05T21:40:02.000Z","date":"2026-02-03","kind":"grant","planned":false,"acquired":true,"shares":2400000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents options to purchase shares of the Issuer's common stock par value $0.0001 per share, pursuant to the Issuer's 2021 Omnibus Equity Incentive Plan, as amended."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The shares underlying the option vest over a four-year period, vesting 1/4 on the one-year anniversary of the date of grant, and the remaining 3/4 vesting pro rata on a monthly basis in 36 equal installments thereafter."}],"balance_after":2400000,"derivative":{"exercise_price":4.45,"expiration_date":"2036-02-03","underlying":"Common Stock","underlying_shares":2400000},"source":{"system":"sec-edgar","filing":"0001193125-26-039524","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1833214/000119312526039524/ownership.xml","form_type":"4"}},{"id":972014,"issuer":{"id":5816,"kind":"organization","name":"SAB Biotherapeutics, Inc.","symbol":"SABS"},"owners":[{"id":35282,"kind":"person","name":"Kropotova Alexandra","position":1,"cik":"0001825323","reported_name":"Kropotova Alexandra","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF MEDICAL OFFICER"}}],"security":"Common Stock","published_at":"2025-12-12T21:45:02.000Z","date":"2025-12-11","kind":"tax_withholding","planned":false,"acquired":false,"shares":988,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares of the Issuer's common stock (\"Common Stock\") withheld to statisfy tax withholding requirements on the vesting of the Issuer's restricked stock units (\"RSUs\")."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Represents shares of the Issuer's common stock (\"Common Stock\") withheld to statisfy tax withholding requirements on the vesting of the Issuer's restricked stock units (\"RSUs\")."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 31,946 shares of Common Stock and 12,338 shares of Common Stock which remain subject to vesting of RSUs granted under the Issuer's 2021 Equity Incentive Plan, as amended."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Each RSU represents a contingent right to receive one share of Common Stock."}],"balance_after":44284,"source":{"system":"sec-edgar","filing":"0001193125-25-317688","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1833214/000119312525317688/ownership.xml","form_type":"4"}},{"id":989865,"issuer":{"id":6906,"kind":"organization","name":"iBio, Inc.","symbol":"IBIO"},"owners":[{"id":35282,"kind":"person","name":"Kropotova Alexandra","position":1,"cik":"0001825323","reported_name":"Kropotova Alexandra","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2025-11-24T21:07:37.000Z","date":"2025-11-20","kind":"grant","planned":false,"acquired":true,"shares":13500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"These options vest pro rata on a monthly basis over twelve months commencing on the date of the grant."},{"field":"shares","element":"transactionShares","label":"F1","text":"These options vest pro rata on a monthly basis over twelve months commencing on the date of the grant."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"These options vest pro rata on a monthly basis over twelve months commencing on the date of the grant."}],"balance_after":13500,"derivative":{"exercise_price":1,"expiration_date":"2035-11-19","underlying":"Common Stock","underlying_shares":13500},"source":{"system":"sec-edgar","filing":"0001104659-25-115409","document":"tm2532045-3_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1420720/000110465925115409/tm2532045-3_4seq1.xml","form_type":"4"}},{"id":1035212,"issuer":{"id":5816,"kind":"organization","name":"SAB Biotherapeutics, Inc.","symbol":"SABS"},"owners":[{"id":35282,"kind":"person","name":"Kropotova Alexandra","position":1,"cik":"0001825323","reported_name":"Kropotova Alexandra","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF MEDICAL OFFICER"}}],"security":"Common Stock","published_at":"2025-09-22T21:00:04.000Z","date":"2025-09-19","kind":"tax_withholding","planned":false,"acquired":false,"shares":1977,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares of the Issuer's common stock (\"Common Stock\") withheld to satisfy tax withholding requirements on the vesting of the Issuer's restricted stock units (\"RSUs\")."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Represents shares of the Issuer's common stock (\"Common Stock\") withheld to satisfy tax withholding requirements on the vesting of the Issuer's restricted stock units (\"RSUs\")."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 29,340 shares of Common Stock and 15,932 shares of Common Stock which remain subject to vesting of RSUs granted under the Issuer's 2021 Equity Incentive Plan, as amended."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Each RSU represents a contingent right to receive one share of Common Stock."}],"balance_after":45272,"source":{"system":"sec-edgar","filing":"0001193125-25-211490","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1833214/000119312525211490/ownership.xml","form_type":"4"}},{"id":1054160,"issuer":{"id":5816,"kind":"organization","name":"SAB Biotherapeutics, Inc.","symbol":"SABS"},"owners":[{"id":35282,"kind":"person","name":"Kropotova Alexandra","position":1,"cik":"0001825323","reported_name":"Kropotova Alexandra","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF MEDICAL OFFICER"}}],"security":"Stock Option (right to buy)","published_at":"2025-08-28T21:00:12.000Z","date":"2025-08-26","kind":"grant","planned":false,"acquired":true,"shares":2400000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents options to purchase shares of the Issuer's common stock par value $0.0001 per share (\"Common Stock\"), pursuant to the Issuer's 2021 Omnibus Equity Incentive Plan, as amended (the \"Plan\")."},{"field":"shares","element":"transactionShares","label":"F2","text":"The awards are subject to the Company's receipt of stockholder approval to amend the Plan, to increase the number of shares of Common Stock available for issuance thereunder."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The shares of Common Stock underlying the option vest over a four-year period, vesting 1/4 on March 1, 2026, and the remaining 3/4 vesting pro rata on a monthly basis in 36 equal installments thereafter."}],"balance_after":2400000,"derivative":{"exercise_price":2.17,"expiration_date":"2035-08-26","underlying":"Common Stock","underlying_shares":2400000},"source":{"system":"sec-edgar","filing":"0000950170-25-112047","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1833214/000095017025112047/ownership.xml","form_type":"4"}},{"id":1187278,"issuer":{"id":5816,"kind":"organization","name":"SAB Biotherapeutics, Inc.","symbol":"SABS"},"owners":[{"id":35282,"kind":"person","name":"Kropotova Alexandra","position":1,"cik":"0001825323","reported_name":"Kropotova Alexandra","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF MEDICAL OFFICER"}}],"security":"Common Stock","published_at":"2025-04-01T20:19:49.000Z","date":"2025-03-27","kind":"tax_withholding","planned":false,"acquired":false,"shares":1179,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Represents shares of the Issuer's common stock (\"Common Stock\") withheld to satisfy tax withholding requirements on the vesting of the Issuer's restricted stock units (\"RSUs\")."},{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares of the Issuer's common stock (\"Common Stock\") withheld to satisfy tax withholding requirements on the vesting of the Issuer's restricted stock units (\"RSUs\")."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Represents shares of the Issuer's common stock (\"Common Stock\") withheld to satisfy tax withholding requirements on the vesting of the Issuer's restricted stock units (\"RSUs\")."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 24,128 shares of Common Stock and 23,121 shares of Common Stock which remain subject to vesting of RSUs granted under the Issuer's 2021 Equity Incentive Plan, as amended."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Each RSU represents a contingent right to receive one share of Common Stock."}],"balance_after":47249,"source":{"system":"sec-edgar","filing":"0000950170-25-048551","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1833214/000095017025048551/ownership.xml","form_type":"4"}},{"id":1320126,"issuer":{"id":5816,"kind":"organization","name":"SAB Biotherapeutics, Inc.","symbol":"SABS"},"owners":[{"id":35282,"kind":"person","name":"Kropotova Alexandra","position":1,"cik":"0001825323","reported_name":"Kropotova Alexandra","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF MEDICAL OFFICER"}}],"security":"Common Stock","published_at":"2024-12-31T22:49:34.000Z","date":"2024-12-18","kind":"tax_withholding","planned":false,"acquired":false,"shares":9072,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Represents shares of the Issuer's common stock (\"Common Stock\") withheld to satisfy tax withholding requirements on the vesting of the Issuer's restricted stock units (\"RSUs\")."},{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares of the Issuer's common stock (\"Common Stock\") withheld to satisfy tax withholding requirements on the vesting of the Issuer's restricted stock units (\"RSUs\")."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Represents shares of the Issuer's common stock (\"Common Stock\") withheld to satisfy tax withholding requirements on the vesting of the Issuer's restricted stock units (\"RSUs\")."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 21,712 shares of Common Stock and 26,716 shares of Common Stock which remain subject to vesting of RSUs granted under the Issuer's 2021 Equity Incentive Plan, as amended."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Each RSU represents a contingent right to receive one share of Common Stock."}],"balance_after":48428,"source":{"system":"sec-edgar","filing":"0000950170-24-141672","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1833214/000095017024141672/ownership.xml","form_type":"4"}},{"id":1352560,"issuer":{"id":6906,"kind":"organization","name":"iBio, Inc.","symbol":"IBIO"},"owners":[{"id":35282,"kind":"person","name":"Kropotova Alexandra","position":1,"cik":"0001825323","reported_name":"Kropotova Alexandra","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2024-11-25T21:32:50.000Z","date":"2024-11-21","kind":"grant","planned":false,"acquired":true,"shares":18900,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"These options vest pro rata on a monthly basis over twelve months commencing on the date of the grant."},{"field":"shares","element":"transactionShares","label":"F1","text":"These options vest pro rata on a monthly basis over twelve months commencing on the date of the grant."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"These options vest pro rata on a monthly basis over twelve months commencing on the date of the grant."}],"balance_after":18900,"derivative":{"exercise_price":2.45,"expiration_date":"2034-11-20","underlying":"Common Stock","underlying_shares":18900},"source":{"system":"sec-edgar","filing":"0001104659-24-122592","document":"tm2429436-4_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1420720/000110465924122592/tm2429436-4_4seq1.xml","form_type":"4"}},{"id":1623698,"issuer":{"id":5816,"kind":"organization","name":"SAB Biotherapeutics, Inc.","symbol":"SABS"},"owners":[{"id":35282,"kind":"person","name":"Kropotova Alexandra","position":1,"cik":"0001825323","reported_name":"Kropotova Alexandra","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF MEDICAL OFFICER"}}],"security":"Employee Stock Option (right to buy)","published_at":"2024-02-23T22:00:34.000Z","date":"2024-02-21","kind":"grant","planned":false,"acquired":true,"shares":140000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents options to purchase shares of common stock pursuant to the Company's 2021 Omnibus Equity Incentive Plan."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The shares underlying the option vest over a four-year period, vesting 1/4 on the one-year anniversary of the date of grant, and the remaining 3/4 vesting pro rata on a monthly basis in 36 equal installments thereafter."}],"balance_after":140000,"derivative":{"exercise_price":5.17,"expiration_date":"2034-02-21","underlying":"Common Stock","underlying_shares":140000},"source":{"system":"sec-edgar","filing":"0000950170-24-019460","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1833214/000095017024019460/ownership.xml","form_type":"4"}},{"id":1951149,"issuer":{"id":5816,"kind":"organization","name":"SAB Biotherapeutics, Inc.","symbol":"SABS"},"owners":[{"id":35282,"kind":"person","name":"Kropotova Alexandra","position":1,"cik":"0001825323","reported_name":"Kropotova Alexandra","relationship":{"officer":true,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2023-03-16T20:30:22.000Z","date":"2023-03-14","kind":"grant","acquired":true,"shares":275000,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Restricted Stock Unit (\"RSU\") award under the 2021 Equity Incentive Plan, which vests over a four-year service period, with the first 25% vesting on March 14, 2024, and the remaining vesting in even monthly increments thereafter. The RSU award is subject to the reporting person's continued employment through the vesting date."},{"field":"shares","element":"transactionShares","label":"F1","text":"Restricted Stock Unit (\"RSU\") award under the 2021 Equity Incentive Plan, which vests over a four-year service period, with the first 25% vesting on March 14, 2024, and the remaining vesting in even monthly increments thereafter. The RSU award is subject to the reporting person's continued employment through the vesting date."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Each RSU represents a contingent right to receive one share of the Issuer's common stock."}],"balance_after":275000,"source":{"system":"sec-edgar","filing":"0001437749-23-006913","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1833214/000143774923006913/rdgdoc.xml","form_type":"4"}},{"id":2158877,"issuer":{"id":5816,"kind":"organization","name":"SAB Biotherapeutics, Inc.","symbol":"SABS"},"owners":[{"id":35282,"kind":"person","name":"Kropotova Alexandra","position":1,"cik":"0001825323","reported_name":"Kropotova Alexandra","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Employee Stock Option (right to buy)","published_at":"2022-09-15T21:00:09.000Z","date":"2022-09-13","kind":"grant","acquired":true,"shares":18325,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents options to purchase shares of common stock pursuant to the Company's 2021 Omnibus Equity Incentive Plan."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The shares underlying the option vest over a four-year period, vesting 1/4 on the one-year anniversary of the date of grant, and the remaining\n3/4 vesting pro rata on a monthly basis in 36 equal installments thereafter."}],"balance_after":18325,"derivative":{"exercise_price":0.71,"expiration_date":"2032-09-13","underlying":"Common Stock","underlying_shares":18325},"source":{"system":"sec-edgar","filing":"0001209191-22-050093","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1833214/000120919122050093/doc4.xml","form_type":"4"}},{"id":2240901,"issuer":{"id":5816,"kind":"organization","name":"SAB Biotherapeutics, Inc.","symbol":"SABS"},"owners":[{"id":35282,"kind":"person","name":"Kropotova Alexandra","position":1,"cik":"0001825323","reported_name":"Kropotova Alexandra","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2022-06-08T00:00:13.000Z","date":"2022-06-06","kind":"grant","acquired":true,"shares":300000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Restricted Stock Unit (\"RSU\") award under the 2021 Equity Incentive Plan, which vests over a four-year service period, with the first 25% vesting on June 6, 2023, and the remaining vesting in even monthly increments thereafter. The RSU award is subject to the reporting person's continued employment through the vesting date."},{"field":"shares","element":"transactionShares","label":"F1","text":"Restricted Stock Unit (\"RSU\") award under the 2021 Equity Incentive Plan, which vests over a four-year service period, with the first 25% vesting on June 6, 2023, and the remaining vesting in even monthly increments thereafter. The RSU award is subject to the reporting person's continued employment through the vesting date."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Each RSU represents a contingent right to receive one share of the Issuer's common stock."}],"balance_after":300000,"source":{"system":"sec-edgar","filing":"0001209191-22-034919","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1833214/000120919122034919/doc4.xml","form_type":"4"}},{"id":2475332,"issuer":{"id":6906,"kind":"organization","name":"iBio, Inc.","symbol":"IBIO"},"owners":[{"id":35282,"kind":"person","name":"Kropotova Alexandra","position":1,"cik":"0001825323","reported_name":"Kropotova Alexandra","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2021-12-14T00:08:16.000Z","date":"2021-12-09","kind":"grant","acquired":true,"shares":109000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"These options vest pro rata on a monthly basis over 12 months."},{"field":"shares","element":"transactionShares","label":"F1","text":"These options vest pro rata on a monthly basis over 12 months."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"These options vest pro rata on a monthly basis over 12 months."}],"balance_after":109000,"derivative":{"exercise_price":0.6938,"exercise_date":"2022-01-09","expiration_date":"2031-12-08","underlying":"Common Stock","underlying_shares":109000},"source":{"system":"sec-edgar","filing":"0001104659-21-149234","document":"tm2135158-1_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1420720/000110465921149234/tm2135158-1_4seq1.xml","form_type":"4"}},{"id":3005089,"issuer":{"id":6906,"kind":"organization","name":"iBio, Inc.","symbol":"IBIO"},"owners":[{"id":35282,"kind":"person","name":"Kropotova Alexandra","position":1,"cik":"0001825323","reported_name":"Kropotova Alexandra","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option","published_at":"2020-10-16T10:09:28.000Z","date":"2020-10-14","kind":"grant","acquired":true,"shares":100000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These options vest pro rata on a monthly basis over 36 months."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"These options vest pro rata on a monthly basis over 36 months."}],"balance_after":100000,"derivative":{"exercise_price":2.05,"exercise_date":"2020-11-14","expiration_date":"2030-10-13","underlying":"Common Stock","underlying_shares":100000},"source":{"system":"sec-edgar","filing":"0001104659-20-115457","document":"tm2033244d5_form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1420720/000110465920115457/tm2033244d5_form4.xml","form_type":"4"}}]}